This Research Topic aims to highlight advancements in novel techniques and biomaterials developed by industry and other non-academic entities for tissue engineering and regenerative medicine (TERM) research and clinical application. The current topic also takes an interest in the progress of large-scale manufacturing, standardization, and clinical translation of TERM products.
This special collection encourages contributions from scientists, engineers, and managers who are engaged in business/commercial projects to provide their insights and forecasts on the ways in which TERM can be prepared in industry and successfully applied in patients. Authors are encouraged to identify the challenges that need to be overcome before products or services related to the TERM field become manufacturable.
This Research Topic welcomes the submission of original research, review articles, and mini-reviews. The topics covered by this issue may include:
• Stem cells manufacture and therapeutic efficacy in non-rodent species and human
• Large-scale biofabrication methods
• Clinical case studies regarding the evaluation of biomaterials
• Current challenges of artificial organs like kidney (renal), liver, skin, heart, lungs, etc.
• Tools to evaluate, image and monitor engineered tissues in the clinic
• Safety issues related to clinical TERM products.
• Sterilization and virus clearance approaches
• Economic considerations, models for TERM products et al.
This collection intends to cover both scientific and engineering perspectives, which can facilitate the clinical translation of TERM to benefit patients worldwide. We are also particularly interested in well-described failed projects as learning points for other researchers in this field. No collection of tissue engineering will be complete without mentions of stem cells, renal, liver, and skin, probably the most well-known and successfully commercialized TERM products.
We solicit research papers, experimental-based papers, literature reviews, short focus reviews, and surveys for this collection.
This Research Topic aims to highlight advancements in novel techniques and biomaterials developed by industry and other non-academic entities for tissue engineering and regenerative medicine (TERM) research and clinical application. The current topic also takes an interest in the progress of large-scale manufacturing, standardization, and clinical translation of TERM products.
This special collection encourages contributions from scientists, engineers, and managers who are engaged in business/commercial projects to provide their insights and forecasts on the ways in which TERM can be prepared in industry and successfully applied in patients. Authors are encouraged to identify the challenges that need to be overcome before products or services related to the TERM field become manufacturable.
This Research Topic welcomes the submission of original research, review articles, and mini-reviews. The topics covered by this issue may include:
• Stem cells manufacture and therapeutic efficacy in non-rodent species and human
• Large-scale biofabrication methods
• Clinical case studies regarding the evaluation of biomaterials
• Current challenges of artificial organs like kidney (renal), liver, skin, heart, lungs, etc.
• Tools to evaluate, image and monitor engineered tissues in the clinic
• Safety issues related to clinical TERM products.
• Sterilization and virus clearance approaches
• Economic considerations, models for TERM products et al.
This collection intends to cover both scientific and engineering perspectives, which can facilitate the clinical translation of TERM to benefit patients worldwide. We are also particularly interested in well-described failed projects as learning points for other researchers in this field. No collection of tissue engineering will be complete without mentions of stem cells, renal, liver, and skin, probably the most well-known and successfully commercialized TERM products.
We solicit research papers, experimental-based papers, literature reviews, short focus reviews, and surveys for this collection.